The global digital biomarkers market is set to witness a growth rate of 20% in the next 5 years. Rising prevalence of chronic diseases, growing adoption of wearables and smart devices, shift toward ...

In response to growing market demand for tools that address these concerns, CN Bio has expanded the in vitro to in vivo extrapolation (IVIVE) capabilities of its established PhysioMimix ® DILI ...

Accessible through the Company’s CRS, the new offering harnesses the longstanding expertise of CN Bio’s scientific team to provide detailed data analysis, optimized outcomes, and data-driven ...

BioWorld Content on 'DILI'According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), drug-induced liver injury (DILI) is the leading cause of acute liver failure in the ...

HPVseq is an cross-institutional research group with three the main goals, To discover HPV biomarkers, delineate HPV evolution and develop HPV detection and characterization methods. The microbiome as ...

Doctors use biomarkers to assess a person's health, diagnose and monitor disease progression, and determine how a person's body is responding to treatment. Learn more.

From simple physiological measurements and small molecules to imaging and histologic information, biomarkers found within the human body reveal valuable insights into health and disease. These key ...

A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are emerging as important for guiding ovarian cancer therapy, including ...

Imaging tests like X-rays are another subcategory of biomarkers. Other biomarkers might analyze a component of a person’s blood, urine, cerebrospinal fluid, saliva, or stool. Most often, people mean ...

Mechanism-driven biomarkers can introduce crucial in-human data about the biological processes involved in a disease or its treatment, as well as essential safety data. Combined with preclinical data, ...

Biomarkers can also tell how well a treatment works for you over a period of time. Because of this, experts are looking at how biomarker testing can replace image-based tests like CT scans and MRIs.

Summary Biomarkers are revolutionizing disease diagnosis and treatment by enabling early detection and personalized medicine. The market, valued at $272 million in 2024, is projected to reach $446 ...